AKT1 and breast carcinoma: Given that inhibition of Akt1 enhanced breast cancer metastasis in mice, and many pan-AKT inhibitors are currently undergoing clinical trails for breast cancer treatment [5, 54], it is of particular importance to determine whether such inhibitors may induce metastasis in the treatment of breast cancer.